Enzon Pharmaceuticals, Inc. Extends Tender Offer for a Portion of Its Debt

January 8, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) ("Enzon") today announced that it has extended its "Modified Dutch Auction" tender offer for a portion of its 4% Convertible Senior Notes due 2013 (the "Notes").

Twitter
LinkedIn
Facebook
Email
Print